| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/17/2004 | EP1398379A2 Compounds for immunotherapy and diagnosis of tuberculosis |
| 03/17/2004 | EP1398378A1 Nucleic acids isolated in neuroblastoma |
| 03/17/2004 | EP1398377A1 Growth differentation Factor-7 |
| 03/17/2004 | EP1398376A1 Nucleic acids isolated in neuroblastoma |
| 03/17/2004 | EP1398371A1 Infectious HCV pseudo-particles containing functional E1, E2 envelope proteins |
| 03/17/2004 | EP1398328A1 Hydroxyalkyl starch derivatives |
| 03/17/2004 | EP1398327A1 Method of producing hydroxyalkyl starch derivatives |
| 03/17/2004 | EP1398326A2 Monoclonal antibodies against recombinant stratum corneum chymotryptic enzyme (SCCE) |
| 03/17/2004 | EP1398324A1 Use of recombinant gelatin-like proteins as plasma expanders and compositions suitable for plasma substitution |
| 03/17/2004 | EP1398323A1 Murine androgen receptor complex-associated protein |
| 03/17/2004 | EP1398322A1 HASylated polypeptides, especially HASylated erythropoietin |
| 03/17/2004 | EP1398321A1 Forisomes, process for their preparation and their use as molecular machine |
| 03/17/2004 | EP1398038A1 Botulinum toxin pharmaceutical compositions |
| 03/17/2004 | EP1398031A1 Use of 6-amino-quinoline-5,8-quinones and nucleic acids associated with senescence for the treatment of tumors |
| 03/17/2004 | EP1398025A1 Fine inorganic particles having drug included therein, method for preparation thereof and pharmaceutical preparation comprising fine inorganic particles having drug included therein |
| 03/17/2004 | EP1397685A2 Method for diagnosing transmissible spongiform encephalopathy |
| 03/17/2004 | EP1397515A2 Nucleotide sequences involved in plant disease resistance |
| 03/17/2004 | EP1397511A1 Genetic markers for improved disease resistance in animals (bip) |
| 03/17/2004 | EP1397502A2 Dna sequencing of abc transporter or multi drug resistant protein for better environment stress tolerant crops |
| 03/17/2004 | EP1397499A2 Aav helper plasmids for helper virus-free packaging and pseudo typification of aav vectors |
| 03/17/2004 | EP1397498A1 Delections in arterivirus replicons |
| 03/17/2004 | EP1397496A2 Gene therapy for hemophilia a |
| 03/17/2004 | EP1397494A2 Fungal gene cluster associated with pathogenesis |
| 03/17/2004 | EP1397493A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/17/2004 | EP1397492A2 Modified and stabilized gdf propeptides and uses thereof |
| 03/17/2004 | EP1397484A2 Methods and products related to fgf dimerization |
| 03/17/2004 | EP1397386A2 Chimeric proteins for cell targeting and apoptosis induction and methods of using the same |
| 03/17/2004 | EP1397384A2 Antimicrobially active peptide |
| 03/17/2004 | EP1397383A2 Secreted polypeptide and their use in the treatment of bone disorders |
| 03/17/2004 | EP1397382A2 Novel estrogen receptor ligand binding domain variants and novel ligands and pharmaceutical compositions |
| 03/17/2004 | EP1397381A2 Gene expression during meningococcus adhesion |
| 03/17/2004 | EP1397380A2 Multiple antigenic peptide displaying multiple copies of an epitope of a plaque-forming polypeptide and methods of using same |
| 03/17/2004 | EP1397154A2 Abin-mediated hepatitis protection |
| 03/17/2004 | EP1397153A2 Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules |
| 03/17/2004 | EP1397151A2 Wnv core protein/capsid interacting protein and uses of the same |
| 03/17/2004 | EP1397150A2 Somatostatin agonists |
| 03/17/2004 | EP1397036A2 Xrcc1 and uses thereof |
| 03/17/2004 | EP1397035A1 Method for modifying a plant phenotype |
| 03/17/2004 | EP1307609B1 Continuous electrolytic pickling method for metallic products using alternate current supplied cells |
| 03/17/2004 | EP1240201A4 Oxidized apolipoproteins and methods of use |
| 03/17/2004 | EP1079851A4 Use of anti-prolactin agents to treat proliferative conditions |
| 03/17/2004 | EP1019714A4 Diagnosis of williams syndrome and williams syndrome cognitive profile by analysis of the presence or absence of a lim-kinase gene |
| 03/17/2004 | EP1015608B1 Methods of assaying receptor activity and constructs useful in such methods |
| 03/17/2004 | EP0996633B1 Anti-inflammatory peptides derived from c-reactive protein |
| 03/17/2004 | EP0975775B1 Regulatory system for inducible expression of genes with lambdoid promoters |
| 03/17/2004 | EP0973546B1 Stabilized human papillomavirus formulations |
| 03/17/2004 | EP0952981B1 Method for producing a correctly folded, biological active recombinant protein |
| 03/17/2004 | EP0915974B1 Modified tie-2-receptor ligands |
| 03/17/2004 | EP0762881B1 Use of active agents for the manufacture of medicaments for the treatment of rheumatoid arthritis |
| 03/17/2004 | EP0573611B1 Improved epitode displaying phage |
| 03/17/2004 | EP0557469B1 Plant medium-chain thioesterases |
| 03/17/2004 | CN1483081A New prkag3 allele and its application as genesis and fleshy deseription genetic mark |
| 03/17/2004 | CN1483041A GLP-1 fusion protein |
| 03/17/2004 | CN1483040A Heart ankyrin repeat protein gene upstream sequence, carrier containing the same sequence and usage thereof |
| 03/17/2004 | CN1482918A Modulation of smr1-nep interactions in cns disorders giving rise to mental disorders |
| 03/17/2004 | CN1482917A New therapeutic uses of smr1 peptides |
| 03/17/2004 | CN1482916A Vaccine composite containing invert growth factor a |
| 03/17/2004 | CN1482253A Growth hormone gene of southern siluroid |
| 03/17/2004 | CN1482245A Fragrant citrus iron chelating reductase gene |
| 03/17/2004 | CN1482244A Specific gene NASG coding protein for man nasopharynx tissue and preparation of antibody |
| 03/17/2004 | CN1482243A Acquistion of nasopharyngeal cancer relatived gene NGX6 expression product and preparation of antibody |
| 03/17/2004 | CN1482144A Method for preparing galactomannanpeptide and product |
| 03/17/2004 | CN1482141A Method for preparing specific composite IgY against periodontal disease and group system thereof |
| 03/17/2004 | CN1482140A Process for extracting medicinal protein from ostrich blood and use thereof |
| 03/17/2004 | CN1482139A Mucroslysin protein and gene thereof |
| 03/17/2004 | CN1482138A Process for the separating gynostemma pentaphylla ribosome inactivation protein, product and encoding gene thereof |
| 03/17/2004 | CN1142281C Production method of recombined erythropoietin preparation |
| 03/17/2004 | CN1142277C Method for identifying toxicity attenuated chickenpox virus OKA strain |
| 03/17/2004 | CN1142274C Polypeptide having cell withering promoting activity |
| 03/17/2004 | CN1142272C Use of recombined adenovirus carrying hepatocyte growth factor gene |
| 03/17/2004 | CN1142182C Macroweb bombinator antisperm polypeptide and its preparation process and use in medicine |
| 03/17/2004 | CN1142181C Giant web bombinator polypeptide and its application for preparing anticancer and anti-AIDS medicines |
| 03/17/2004 | CN1142180C Giant web bombinator proteinase inhibitor and its prepn. and pharmaceutical application |
| 03/17/2004 | CN1142179C Multifunctional mycoprotein product for plant and its prepn |
| 03/17/2004 | CN1142177C Isolated MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof |
| 03/16/2004 | US6708120 Computer readable memory; analyzing interaction with rotamers; ranking by dead-end elimination (dee) computation |
| 03/16/2004 | US6706952 Arabidopsis gene encoding a protein involved in the regulation of SAR gene expression in plants |
| 03/16/2004 | US6706949 Isolated polynucleotide comprising specified nucleic acid sequence which encodes polypeptide with ruvb activity or nucleic acid sequence which is fully complementary; homologous recombination |
| 03/16/2004 | US6706948 Purified nucleic acid sequence; promoter sequence capable of driving transgene expression in both monocotyledonous and dicotyledonous plant cells; generating transgenic plants |
| 03/16/2004 | US6706874 Viral nucleotide sequences for use in the prevention and treatment of viral diseases |
| 03/16/2004 | US6706873 Nucleic acid molecule encoding specified amino acid sequence |
| 03/16/2004 | US6706872 Polynucleotides encoding Plasmodium vivax blood stage antigens |
| 03/16/2004 | US6706871 Isolated polynucleotide comprising specified nucleotide sequence which encodes polypeptide having specified amino acid sequence |
| 03/16/2004 | US6706870 Nucleic acids encoding CTLA-8; and related reagents |
| 03/16/2004 | US6706869 Map kinase phosphatases and polynucleotides encoding them |
| 03/16/2004 | US6706866 Plant having altered environmental stress tolerance |
| 03/16/2004 | US6706862 Backbone-cyclized BPI peptidomimetics |
| 03/16/2004 | US6706860 Toxins |
| 03/16/2004 | US6706859 HIV peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV |
| 03/16/2004 | US6706762 Methods for the use of inhibitors of co-repressors for the treatment of neoplastic diseases |
| 03/16/2004 | US6706713 Conjugate for treating inflammatory infectious and/or skin diseases |
| 03/16/2004 | US6706690 Hemoactive compositions and methods for their manufacture and use |
| 03/16/2004 | US6706687 Platelet-derived growth factor D |
| 03/16/2004 | US6706685 Compounds and methods for stimulating β-catenin mediated gene expression and differentiation |
| 03/16/2004 | US6706682 Increasing or maintaining the blood supply in the penis |
| 03/16/2004 | US6706523 Nucleoprotein is mutated at the amino acid wherein phosphorylation occurs |
| 03/16/2004 | US6706522 Recombinant dna construction comprising open reading frame with specified sequence placed under control of non-native promoter; diagnosis or treatment of bubonic plague |
| 03/16/2004 | US6706514 Polypeptides capable of interacting with the human topoisomerase IIIα |
| 03/16/2004 | US6706503 Generating preferential microorganisms; obtain microorganism containing mutant gene, express gene and evaluate microorganism mutation response |
| 03/16/2004 | US6706496 Method for expression of heterologous proteins in yeast |